News

The Centers for Disease Control and Prevention (CDC) is calling for routine meningococcal disease vaccination to be given during preadolescent doctors’ visits between the ages of 11 to

The FDA approval is based on results from one of the largest studies conducted to date of hospitalized patients with complicated skin and skin structure infections (cSSSI). The

The findings have been described as highly significant for systemic onset juvenile idiopathic arthritis (SoJIA) patients for whom previous therapies have failed. In a study of nine SoJIA

This is the second time in recent weeks that the FDA has denied approval of Risperdal (risperidone) for the treatment of a new disease. Earlier this month Johnson

Myogen has also achieved three development milestones under an existing research collaboration with Novartis, which has been in operation since 2003. Achievement of these milestones will trigger payments

The European Patent Organization granted the patent for the Mycobacterial Cell Wall-DNA Complex (MCC), which comprises compositions with antiviral, immune adjuvant, and immune stimulatory activity, as well as

AP23573 was recently designated as a fast-track product by the FDA for the treatment of sarcomas. Ariad hopes oral administration would permit greater flexibility in dosing and greater

The research suggests Virulizin activates the innate immune system of the host. Previous studies have shown that Virulizin induces the antitumor activity of macrophages, and that natural killer

This testing is intended to support a larger scale study planned for later this year as part of the US regulatory approval process. Scolr Pharma received authorization from